Vimarsana
Biggest News Aggregation in the World

Page 10 - Quest Diagnostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Quest Diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Quest Diagnostic Today - Breaking & Trending Today

Q3 2023 Earnings Forecast for Quest Diagnostics Incorporated Issued By Zacks Research (NYSE:DGX) - Vimarsana News

Q3 2023 Earnings Forecast for Quest Diagnostics Incorporated Issued By Zacks Research (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Research analysts at Zacks Research increased their Q3 2023 earnings per share estimates for shares of Quest Diagnostics in a research note issued on Monday, October 16th. Zacks Research analyst M. Mondal now expects that the medical research company will post earnings per share of $2.15 for […]

Marijuana and the workplace: Will legalization in Ohio increase accidents or not? - Vimarsana News

Marijuana and the workplace: Will legalization in Ohio increase accidents or not?

Does legalization of recreational marijuana pose a danger to the workplace? Depends on who you ask.

Source: yahoo.com
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall - Vimarsana News

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...

Source: yahoo.com
Medtech Funding Expected to Pick Up In 2023 After Q1's Low Point - Vimarsana News

Medtech Funding Expected to Pick Up In 2023 After Q1's Low Point

Medtech funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023, according to a new Pitchbook report. It noted that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even come in below last year’s funding total of $13.5 billion.

Zacks Research Equities Analysts Cut Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX) - Vimarsana News

Zacks Research Equities Analysts Cut Earnings Estimates for Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX – Free Report) – Equities research analysts at Zacks Research reduced their Q3 2023 earnings per share (EPS) estimates for shares of Quest Diagnostics in a research report issued on Wednesday, August 9th. Zacks Research analyst M. Mondal now forecasts that the medical research company will post earnings of $2.14 per […]